Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Adaptive Biotechnologies Corp
About ADPT
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company focuses on the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its technologies to read the genetic code of a patient's immune system. It operates through two segments, which include Minimal Residual Disease (MRD) and Immune Medicine. The MRD business focuses on the use of its sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. Its MRD business is comprised of its clonoSEQ clinical diagnostic testing service, offered to clinicians. Its Immune Medicine business focuses on immune-repertoire sequencing, target antigen discovery, data licensing and TCR-antigen prediction models in the identification, validation, development and adoption of products and services.
Find out what a historical investment in Adaptive Biotechnologies Corp would be worth today using our ADPT stock calculator.
Market Capitalisation
$2.67B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.22M
High today
$17.53
Low today
$16.54
Open price
$16.93
52-week high
$20.76
52-week low
$9.90
Ready to start your investing journey with Stake?
Open an accountHow do I buy ADPT shares in Australia?
Buying ADPT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Adaptive Biotechnologies Corp in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ADPT
What is the ticker symbol of Adaptive Biotechnologies Corp?
The ticker symbol for Adaptive Biotechnologies Corp is ADPT.
How much is one share of ADPT?
One share of ADPT is valued at $17.27 as of 10 June 2026.
What is the market capitalisation of Adaptive Biotechnologies Corp ADPT?
As of 10 June 2026 Adaptive Biotechnologies Corp has a market cap of $2.67B.
What is the 52-week high for Adaptive Biotechnologies Corp stock?
The Adaptive Biotechnologies Corp 52-week high stock price is $20.76.
What is the 52-week low for Adaptive Biotechnologies Corp stock?
The Adaptive Biotechnologies Corp 52-week low stock price is $9.90.
Can I buy ADPT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ADPT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ADPT on Stake
- Buy ADPT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ADPT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ADPT related stocks